chr7-155458531-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001427.4(EN2):c.154G>T(p.Ala52Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000778 in 1,374,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001427.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000725 AC: 11AN: 151662Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000785 AC: 96AN: 1222934Hom.: 0 Cov.: 30 AF XY: 0.0000937 AC XY: 56AN XY: 597718
GnomAD4 genome AF: 0.0000725 AC: 11AN: 151662Hom.: 0 Cov.: 33 AF XY: 0.0000540 AC XY: 4AN XY: 74094
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 11, 2024 | The c.154G>T (p.A52S) alteration is located in exon 1 (coding exon 1) of the EN2 gene. This alteration results from a G to T substitution at nucleotide position 154, causing the alanine (A) at amino acid position 52 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at